These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 226558

  • 1. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes.
    Kishihara M, Nakao Y, Baba Y, Matsukura S, Kuma K, Fujita T.
    J Clin Endocrinol Metab; 1979 Nov; 49(5):706-11. PubMed ID: 226558
    [Abstract] [Full Text] [Related]

  • 2. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M, Nakao Y, Baba Y, Kobayashi N, Matsukura S, Kuma K, Fujita T.
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [Abstract] [Full Text] [Related]

  • 3. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR, Lukes YG, Smallridge RC, Berger M, Burman KD.
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [Abstract] [Full Text] [Related]

  • 4. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P, Harrison LC.
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [Abstract] [Full Text] [Related]

  • 5. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
    Abe Y.
    Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
    [Abstract] [Full Text] [Related]

  • 6. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T, Villadolid MC, Ingbar SH.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [Abstract] [Full Text] [Related]

  • 7. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
    Loeffler M, Zakarija M, McKenzie JM.
    J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
    [Abstract] [Full Text] [Related]

  • 8. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease.
    Shinozawa T, Villadolid MC, Ingbar SH.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174
    [Abstract] [Full Text] [Related]

  • 9. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M, Ingbar JC, Kubota K, Amir SM, Ingbar SH.
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [Abstract] [Full Text] [Related]

  • 10. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
    Davies TF, Platzer M.
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease.
    O'Donnell J, Trokoudes K, Silverberg J, Row V, Volpé R.
    J Clin Endocrinol Metab; 1978 May; 46(5):770-7. PubMed ID: 233633
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system.
    Carayon P, Adler G, Roulier R, Lissitzky S.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1202-8. PubMed ID: 6302125
    [Abstract] [Full Text] [Related]

  • 18. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.
    Baker JR, Lukes YG, Burman KD.
    J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714
    [Abstract] [Full Text] [Related]

  • 19. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study.
    Strakosch CR, Joyner D, Manley SW, Wall JR.
    Clin Endocrinol (Oxf); 1982 Aug; 17(2):173-9. PubMed ID: 6127179
    [Abstract] [Full Text] [Related]

  • 20. Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases.
    Tao TW, Kriss JP.
    J Clin Endocrinol Metab; 1982 Nov; 55(5):935-40. PubMed ID: 6126489
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.